Incidental primary breast cancer detected on surveillance 68Ga-DOTATATE PET/CT in a patient with metastatic neuroendocrine carcinoma

Research output: Contribution to journalArticle

Abstract

We present a case of a 53-year-old woman with metastatic neuroendocrine tumor, presumed primary in the small intestine with metastases to the liver and mesenteric lymph nodes. The patient was being treated with lanreotide and followed with somatostatin receptor (SSTR)-targeted 68Ga-labeled 1,4,7,10-tetraazacyclododecane-N,N', N'',N'''-tetraacetic acid-d-Phe(1)-Tyr(3)-octreotate (68Ga-DOTATATE) positron emission tomography – computed tomography (PET/CT). On a follow-up exam, the patient's primary and metastatic disease had improved but she had new 68Ga-DOTATATE-avid lesions in the right breast and right axilla. Subsequent breast imaging workup and biopsy demonstrated a primary breast cancer and axillary lymph node metastasis.

Original languageEnglish (US)
Pages (from-to)1344-1347
Number of pages4
JournalRadiology Case Reports
Volume15
Issue number8
DOIs
StatePublished - Aug 2020

Keywords

  • Breast neoplasm
  • Dotatate PET/CT
  • Neuroendocrine carcinoma
  • Somatostatin receptor imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Incidental primary breast cancer detected on surveillance <sup>68</sup>Ga-DOTATATE PET/CT in a patient with metastatic neuroendocrine carcinoma'. Together they form a unique fingerprint.

  • Cite this